See more : PORR AG (POS.VI) Income Statement Analysis – Financial Results
Complete financial analysis of Viemed Healthcare, Inc. (VMD.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Viemed Healthcare, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Pro-Hawk Corporation (8083.TWO) Income Statement Analysis – Financial Results
- Descrypto Holdings, Inc. (DSRO) Income Statement Analysis – Financial Results
- Sinopec Shanghai Petrochemical Company Limited (600688.SS) Income Statement Analysis – Financial Results
- Maj Invest Value Aktier (MAJVAL.CO) Income Statement Analysis – Financial Results
- Queen’s Gambit Growth Capital (GMBT) Income Statement Analysis – Financial Results
Viemed Healthcare, Inc. (VMD.TO)
About Viemed Healthcare, Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|
Revenue | 138.83M | 117.06M | 131.31M | 80.26M | 65.27M | 46.93M | 31.36M |
Cost of Revenue | 54.15M | 43.65M | 51.20M | 24.25M | 16.69M | 12.31M | 12.50M |
Gross Profit | 84.68M | 73.41M | 80.11M | 56.01M | 48.58M | 34.62M | 18.86M |
Gross Profit Ratio | 60.99% | 62.71% | 61.01% | 69.78% | 74.43% | 73.76% | 60.14% |
Research & Development | 2.70M | 2.11M | 1.08M | 848.00K | 0.00 | 0.00 | 0.00 |
General & Administrative | 73.36M | 60.04M | 57.71M | 45.27M | 30.68M | 20.25M | 13.77M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 268.00K | 0.00 | 0.00 |
SG&A | 73.36M | 60.04M | 57.71M | 45.27M | 30.95M | 20.25M | 13.77M |
Other Expenses | 23.00K | -771.00K | -3.14M | 671.00K | -71.00K | 402.00K | 332.00K |
Operating Expenses | 76.08M | 61.38M | 55.66M | 46.79M | 31.54M | 20.65M | 14.10M |
Cost & Expenses | 130.23M | 105.03M | 106.86M | 71.04M | 48.23M | 32.96M | 26.60M |
Interest Income | 197.00K | 318.00K | 509.00K | 314.00K | 0.00 | 0.00 | 0.00 |
Interest Expense | 197.00K | 318.00K | 509.00K | 314.00K | 181.00K | 272.00K | 323.00K |
Depreciation & Amortization | 16.32M | 12.21M | 7.35M | 6.87M | 3.78M | 2.54M | 1.42M |
EBITDA | 24.57M | 23.79M | 34.13M | 15.62M | 13.89M | 11.37M | 1.81M |
EBITDA Ratio | 17.70% | 20.32% | 25.99% | 19.46% | 31.91% | 35.18% | 19.72% |
Operating Income | 8.25M | 11.58M | 26.78M | 8.75M | 17.05M | 8.82M | 383.00K |
Operating Income Ratio | 5.94% | 9.89% | 20.40% | 10.90% | 26.11% | 18.80% | 1.22% |
Total Other Income/Expenses | 792.00K | 1.98M | 5.41M | -421.00K | 229.00K | -633.00K | -274.00K |
Income Before Tax | 8.99M | 12.50M | 26.36M | 8.80M | 10.34M | 8.19M | 109.00K |
Income Before Tax Ratio | 6.48% | 10.68% | 20.08% | 10.96% | 15.84% | 17.45% | 0.35% |
Income Tax Expense | 2.77M | 3.38M | -5.17M | 271.00K | 162.00K | 15.00K | -1.12M |
Net Income | 6.22M | 9.13M | 31.53M | 8.53M | 10.18M | 8.18M | 1.23M |
Net Income Ratio | 4.48% | 7.80% | 24.01% | 10.62% | 15.59% | 17.42% | 3.92% |
EPS | 0.16 | 0.23 | 0.81 | 0.23 | 0.26 | 0.22 | 0.03 |
EPS Diluted | 0.16 | 0.22 | 0.78 | 0.21 | 0.26 | 0.22 | 0.03 |
Weighted Avg Shares Out | 38.66M | 39.49M | 38.74M | 39.75M | 37.89M | 37.91M | 37.91M |
Weighted Avg Shares Out (Dil) | 39.81M | 40.68M | 40.53M | 39.75M | 39.68M | 37.97M | 37.91M |
Source: https://incomestatements.info
Category: Stock Reports